T cell immunity to seasonal Influenza A and H5N1 viruses in laboratory workers receiving annual seasonal Influenza vaccines
These results highlight the potential for influenza vaccines to elicit cross-reactive immunity against H5N1 viruses. These findings also demonstrate differences between T cell responses to influenza and SARS-CoV-2, highlighting distinct immune profiles that could inform future vaccine strategies.
Authors
- Joel N. Blankson (ORCID: https://orcid.org/0000-0002-9683-8021)
- Kellie N. Smith (ORCID: https://orcid.org/0000-0002-6295-8930)
- L. Gutiérrez (ORCID: https://orcid.org/0000-0002-4161-2711)
- Joel Sop
- Tyler P. Beckey
- Li Zhang (ORCID: https://orcid.org/0000-0002-9687-8293)
- Kelly A. Gebo
Institutions
- Bloomberg (United States) (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Sidney Kimmel Cancer Center (US)
- Johns Hopkins Hospital (US)
- Sidney Kimmel Comprehensive Cancer Center (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3389/fimmu.2025.1718805
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Johns Hopkins University